Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.

@article{Song2003DoublephaseTM,
  title={Double-phase Tc-99m MIBI scintigraphy as a therapeutic predictor in patients with non-Hodgkin's lymphoma.},
  author={H C Song and Je-Jung Lee and Hee-Seung Bom and I. F. Chung and Hyeoung-Joon Kim and Young Kyu Park and Edmund E. Kim},
  journal={Clinical nuclear medicine},
  year={2003},
  volume={28 6},
  pages={457-62}
}
PURPOSE Tc-99m MIBI is a promising agent for the functional characterization of P-glycoprotein expression and the prediction of therapeutic outcome in human tumors. The purpose of this study was to determine whether tumor clearance of Tc-99m MIBI may have a predictive value in the clinical outcome in patients with non-Hodgkin's lymphoma. METHODS Seventeen… CONTINUE READING